Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- An association between low serum alpha-fetoprotein and fetal chromosomal abnormalities.Am J Obstet Gynecol. 1984; 148: 886-894
- Maternal serum alpha-fetoprotein measurement: a screening test for Down syndrome.Lancet. 1984; 1: 926-929
- Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels.N Engl J Med. 1987; 317: 342-346
- ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities.Obstet Gynecol. 2007; 109: 217-227
- Options for Down syndrome screening: what will women choose?.J Midwifery Womens Health. 2005; 50: 211-218
- Women and health care professionals' preferences for Down's syndrome screening tests: a conjoint analysis study.BJOG. 2004; 111: 775-779
- Women's and healthcare professionals' preferences in prenatal testing for Down syndrome in Australia.Aust N Z J Obstet Gynaecol. 2006; 46: 205-211
- Screening options for Down syndrome: how women choose in real clinical setting.Prenat Diagn. 2009; 29: 852-856
- First-trimester and early second-trimester diagnosis of nuchal cystic hygroma by transvaginal sonography: diverse prognosis of the septated from the nonseptated lesion.Am J Obstet Gynecol. 1990; 163: 267-269
- Diagnosis and significance of cystic hygroma in the first trimester.Prenat Diagn. 1990; 10: 643-651
- Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities.Am J Obstet Gynecol. 2004; 191: 45-67
- UK multicenter project on detection rate for other chromosome defects trisomy 18 assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestation.Lancet. 1998; 352: 343-346
- First-trimester screening for aneuploidy: research or standard of care?.Am J Obstet Gynecol. 2000; 182: 490-496
- The 11–14 week scan.Baillieres Best Pract Res Clin Obstet Gynaecol. 2000; 14: 581-594
- First-trimester trisomy screening: nuchal translucency measurement training and quality assurance to correct and unify technique.Ultrasound Obstet Gynecol. 2002; 19: 353-359
- Nuchal translucency measurement in normal fetuses.Obstet Gynecol. 1995; 86: 994-997
- Optimising the timing for nuchal translucency measurement.Prenat Diagn. 2002; 22: 775-777
- First trimester screening for trisomy 21 and 18.N Engl J Med. 2003; 349: 1405-1413
- First-trimester or second-trimester screening, or both, for Down's syndrome.N Engl J Med. 2005; 353: 2001-2011
- SURUSS in perspective.BJOG. 2004; 111: 521-531
- Aneuploidy screening in the first trimester.Am J Med Genet C Semin Med Genet. 2007; 145C: 18-32
- Antenatal screening for Down's syndrome.Health Technol Assess. 1998; 2: 9-32
- Screening of maternal serum for fetal Down's syndrome in the first trimester.N Engl J Med. 1998; 338: 955-961
- Free beta human chorionic gonadtropin in Down syndrome screenings: a multicenter study of its role compared with other biochemical markers.Ann Clin Biochem. 1992; 30: 512-518
- First and second trimester antenatal screening for Down's syndrome: the results of Serum Urine and Ultrasound Screening Study (SURUSS).J Med Screen. 2003; 10: 56-104
- A screening program for trisomy 21 at 10–14 weeks using total nuchal translucency, maternal serum free ß-human chorionic gonadotropin and pregnancy.Ultrasound Obstet Gynecol. 1999; 13: 231-237
- A summary analysis of Down syndrome markers in the late first trimester.Adv Clin Chem. 2007; 43: 177-210
- Performance of first trimester screening between gestational weeks 7 and 13.Clin Chem. 2009; 55: 1564-1567
- Maternal serum levels of dimeric inhibin A in pregnancies affected by trisomy 21 in the first trimester.Prenat Diagn. 2001; 21: 441-444
- First trimester serum screening for Down's syndrome.Prenat Diagn. 1995; 15 ([erratum in: Prenat Diagn 1996;16(4):387]): 1227-1240
- Bead-based multiplexed immunoassays to identify new biomarker in maternal serum to improve first trimester Down syndrome screening.Prenat Diagn. 2009; 29: 857-862
- Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies.Am J Obstet Gynecol. 2005; 192: 1761-1767
- Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters.N Engl J Med. 1999; 341: 461-467
- Assessment of the value of reporting partial screening results in prenatal screening for Down syndrome.Prenat Diagn. 2001; 21: 737-740
- An outcomes analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years.Am J Obstet Gynecol. 2004; 190: 721-729
- A cost-effectiveness analysis of prenatal screening strategies for Down syndrome.Obstet Gynecol. 2005; 106 ([erratum in: Obstet Gynecol 2006;107(1):209]): 562-568
- Prenatal screening for Down's syndrome–a search for the family's values.N Engl J Med. 1999; 341 ([comment in: N Engl J Med 1999;341(25):1935–6; author reply: 1937; comment on: N Engl J Med 1999;341(7):461–7]): 521-522
- Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening.Ultrasound Obstet Gynecol. 2005; 25: 221-226
- Contingent screening for Down syndrome is an efficient alternative to non-disclosure sequential screening.Prenat Diagn. 2004; 24: 762-766
- Sequential pathways of testing after first trimester screening for trisomy 21.Obstet Gynecol. 2004; 104: 661-666
- Sequential pathways of testing after first-trimester screening for trisomy 21.Obstet Gynecol. 2005; 105 ([author reply: 438–9]): 438
- Down syndrome screening in the United States in 2001 and 2007: a survey of maternal-fetal medicine specialists.Am J Obstet Gynecol. 2009; 201: 97.e1-97.e5
- Antenatal Down syndrome screening in the United States in 2001: a survey of maternal-fetal medicine specialists.Am J Obstet Gynecol. 2002; 187: 1230-1234
- Screening for Down syndrome: changing practice of obstetricians.Am J Obstet Gynecol. 2009; 200: 459.e1-459.e9
Article info
Identification
Copyright
© 2010 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
